These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12402771)

  • 1. [Monotherapy with casodex at a dose of 150 mg--a new method of hormonal treatment of disseminated prostatic cancer].
    Rusakov IG; Alekseev BIa
    Urologiia; 2002; (5):23-6. PubMed ID: 12402771
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary results of casodex use in patients with hormone-resistant cancer of the prostate].
    Matveev BP; Bukharkin BV
    Urologiia; 2001; (6):20-1. PubMed ID: 11785074
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjuvant hormone therapy in prostatic cancer: after treatment with curative intent. The viewpoint of the urologist].
    Martorana G
    Recenti Prog Med; 2002 Mar; 93(3):179-82. PubMed ID: 11942170
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].
    Sivko AV; Prokhorov AV
    Urol Nefrol (Mosk); 1997; (3):49-52. PubMed ID: 9245060
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in prostate-specific antigen in casodex (bicalutamide) monotherapy in a dose 150 mg/day given to patients with locally advanced and/or advanced prostatic cancer].
    Kariakin OB; Sviridova TV; Tsodikova LB; Grishin GN; Sergeeva TN; Perekhrest MA; Donichkina EA
    Urologiia; 2001; (4):26-9. PubMed ID: 11569230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of monotherapy trials with the new anti-androgen, Casodex (ICI 176,334). International Casodex Investigators.
    Iversen P
    Eur Urol; 1994; 26 Suppl 1():5-9. PubMed ID: 7737258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bicalutamide].
    Taéron C
    Rev Infirm; 2010 Mar; (158):47-9. PubMed ID: 20383962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adjuvant treatment of prostatic carcinoma after primary therapy. The "Early Prostate Cancer" Program].
    Mansueto G; Longo F
    Recenti Prog Med; 2002 Mar; 93(3):175-8. PubMed ID: 11942169
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of bicalutamide in adjuvant treatment of prostatic carcinoma after primary therapy with curative aim. The viewpoint of the surgeon].
    Rigatti P; Scattoni V
    Recenti Prog Med; 2002 Mar; 93(3):183-5. PubMed ID: 11942171
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Casodex': defining the role of antiandrogens.
    McCaffrey JA; Scher HI
    Cancer J Sci Am; 1997; 3(4):204-8. PubMed ID: 9263624
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new anti-androgen, bicalutamide (Casodex), for the treatment of prostate cancer--basic clinical aspects].
    Akaza H
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1201-7. PubMed ID: 10431591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The place and the results of monotherapy.
    Bonnet P
    Acta Urol Belg; 1998 May; 66(2):11-5. PubMed ID: 9633120
    [No Abstract]   [Full Text] [Related]  

  • 13. New drug for prostate cancer.
    Eur J Cancer Care (Engl); 2001 Jun; 10(2):79-80. PubMed ID: 11829051
    [No Abstract]   [Full Text] [Related]  

  • 14. New molecules and treatment modulation in advanced prostatic cancer.
    Mahler C; Verhelst J; Denis L
    Acta Urol Belg; 1996 May; 64(2):95-8. PubMed ID: 8701825
    [No Abstract]   [Full Text] [Related]  

  • 15. Bicalutamide ('Casodex') development: from theory to therapy.
    Kolvenbag GJ; Furr BJ
    Cancer J Sci Am; 1997; 3(4):192-203. PubMed ID: 9263623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reevaluation of MAB therapy and progress of endocrine therapy].
    Klotz L; Payne H; Gillatt D; Keane T; Morris C; Akaza H; Hirao ; Akakura K; Fukagai T
    Gan To Kagaku Ryoho; 2005 May; 32(5):705-28. PubMed ID: 15934164
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monotherapy with antiandrogens for prostatic cancer].
    Sander S
    Tidsskr Nor Laegeforen; 1999 Apr; 119(10):1451-3. PubMed ID: 10354754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Casodex: a pure non-steroidal anti-androgen used as monotherapy in advanced prostate cancer.
    Tyrrell CJ
    Prostate Suppl; 1992; 4():97-104. PubMed ID: 1574464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The third analysis of the bicalutamide Early Prostate Cancer programme.
    Iversen P;
    BJU Int; 2006 Mar; 97(3):438-9. PubMed ID: 16469002
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormonal treatment of cancer of the prostate: review and present status].
    Ganzer R; Wieland WF; Bach T; Rössler W; Blana A
    Dtsch Med Wochenschr; 2007 Jan; 132(4):161-6. PubMed ID: 17230333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.